In our weekly Trends that Matter series, we provide engaging infographics from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is biomarker research and development. Biomarkers are used to monitor health status, detect conditions, and select the most effective treatment options. In the pharma industry, biomarkers are also used to determine the safety and effectiveness of drugs based on overall population data and individual patient information.
As biomarker research expands and data access improves, clinicians will have greater ability to deliver personalized care, contributing to the value-based care shift. According to biochemistry research by Timothy J. Hagen and Northern Illinois University:
"The use of genomic data makes it possible to identify subsets of patients that should respond to certain therapies. Successful implementation of biomarkers for personalized medicine will identify a sub-population that should respond well to a certain treatment and reduce risks associated with the drug treatment. This approach will increase the cost and reduce the number of patients prescribed, however these costs should be offset by the increased safety."
Biomarker data also contributes to clinical research. According to Adventist University of Health Sciences, 50% of all clinical trials are now collecting DNA for biomarker development purposes.
In the graphic below, Adventist University of Health Sciences outlines the significance of biomarker data for personalized medicine and genetic research:
Subscribe to the MMIT blog for more insights on trends affecting pharmaceutical manufacturers, providers and payers.